Claims
- 1. A pharmaceutical composition containing as the active ingredient an effective amount, for the treatment of epilepsy, dyskinesiae, memory troubles and psychic troubles, of a glycinamide derivative of the formula: ##STR74## wherein: R is a linear pentyl group, or a linear or branched C.sub.2 -C.sub.5 alkyl group substituted by at least one phenyl group or at least one halo-substituted phenyl group,
- R.sub.1 is hydrogen, and
- R.sub.2 is hydrogen,
- or the non-toxic, pharmaceutically acceptable acid addition salt thereof together with a pharmaceutically acceptable carrier or diluent.
- 2. The pharmaceutical composition according to claim 1 wherein the halo phenyl is substituted with a fluorine, bromine or chlorine atom.
- 3. The pharmaceutical composition according to claim 1 in a unit dose containing from 10 to 300 mg. of said glycinamide derivative.
- 4. A pharmaceutical composition containing as the active ingredient an effective amount of 2-n-pentylaminoacetamide, for the treatment of epilepsy, dyskinesiae, memory troubles and psychic troubles, or the non-toxic, pharmaceutically acceptable acid addition salt thereof together with a pharmaceutically acceptable carrier or diluent.
- 5. A pharmaceutical composition in unit dose form for treating tonic convulsions containing from 10 to 300 mg. of the glycinamide derivative of claim 4.
Priority Claims (2)
Number |
Date |
Country |
Kind |
81068 |
Mar 1979 |
LUX |
|
81069 |
Mar 1979 |
LUX |
|
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a continuation of application Ser. No. 458,756, filed Apr. 21, 1983, now abandoned, which is a continuation of our earlier application Ser. No. 133,102 filed Mar. 24, 1980, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
2368208 |
Epstein |
Jan 1945 |
|
2781385 |
Spivack |
Feb 1957 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
2637M |
May 1963 |
FRX |
Continuations (2)
|
Number |
Date |
Country |
Parent |
458756 |
Apr 1983 |
|
Parent |
133102 |
Mar 1980 |
|